Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a chitosan brush and enamel gel heal deep gum pockets without surgery?

NCT ID NCT06684769

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a non-surgical treatment for deep gum pockets (furcation defects) in people with advanced periodontitis. One side of the mouth gets a chitosan brush plus enamel matrix derivative; the other side gets the brush alone. The goal is to see if the added gel improves gum attachment and reduces bleeding. Forty adults will be followed for 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enamel matrix derivative (Emdogain) applied with an oscillating chitosan brush
What this could lead to
If successful, this could offer a non-surgical way to improve gum attachment and reduce inflammation in deep gum pockets around molars.
What could go wrong
This is a small, early-stage trial with only 40 participants. The benefits may be modest, and results may not apply to all types of gum disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. The patient is 18 years of age or older 2. The patient does not have any systemic diseases that may affect the results of the study 3. The patient has a plaque index of 20% or less at the study entry 4. The patient has a history of severe localized or generalized periodontitis (stage III or IV) 5. Completed the first and second steps of periodontal treatment (According to Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline) (Sanz M. et al.) 6. Buccal and/or lingual Class 2A and/or 2B furcation involvement (FI) defects on both sides of the Mandibular first and/or second molars after completing the first and second steps of periodontal treatment. 7. Buccal Class 2A and/or 2B furcation involvement (FI) defects on both sides of the maxillary first and/or second molars after completion of the first and second step of periodontal treatment if furcation involvement on the palatal side (mesiopalatal and distopalatal) does not exceed Class 1. 8. Psychological appropriateness 9. Consents to all follow-up visits Exclusion Criteria: 1. Patients who have systemic diseases that may affect the results of the study 2. Use of medications that may affect study results (anti-osteoporotic drugs, statins, corticosteroids, anticoagulants) 3. Patients who use calcium channel blockers, cyclosporine A or antiepileptic drugs if there are clinically visible hyperplastic changes in the gingival margin. 4. Patients who have received any type of systemic antibiotics in the last six months prior to the start of the study and patients starting antibiotics during the study 5. Patients requiring antibiotic premedication prior to periodontal treatment 6. Oncological disease 7. Chemotherapy and/or radiotherapy (active or history) 8. Pregnancy and breastfeeding 9. Any condition or current treatment which, in the opinion of the investigator and/or consulting physician, may present an unreasonable risk 10. Psychoemotional disorders and depression 11. Use of antipsychotic medication or antidepressants 12. Lack of patient motivation to undertake adequate dental care at home or complete periodontal treatment, patients residing outside Latvia 13. Molars with combined endodontic-periodontal lesions, active endodontic infection 14. Prosthetic factors for molars not allowing clinical measurements 15. Huge restoration or amalgam fillings that could potentially cause fractures or furcation involvement 16. Enamel pearls or filling or crown margins 17. Decay or root resorption 18. Tooth mobility degree 3 19. Molars in which the gingival margin is positioned apically from the entrance into the furcation area 20. Clinical attachment level and or pockets mesial and distal to the furcation involvement defect of 6 or more mm 21. Strong vomiting reflex that would prevent adequate periodontal treatment 22. People close to the study subjects, work colleagues, relatives, etc.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Furcation defects are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Riga Stradins University Institute of Stomatology

    RECRUITING

    Riga, Latvia

More trials for these conditions

Other studies related to the condition(s) this trial covers.